TAVI possible? @GilbertTangMD @TAVRBot @tavrkapadia @JoaoLCavalcante @bapat_savrtavr

181 bicuspid #TAVR with Acurate neo2: only 4% moderate PVL, mean gradient 6 mmHg, new pacemaker 6%. Read the paper at @EuroInterventio. @dmylotte @MSettergren

RT @EuroInterventio: Just published on the occasion of #PCRLV: The Neo2 BAV registry evaluated the safety and efficacy of ACURATE neo2 in…

@GilbertTangMD I am still worried about longer term downsides with prosthesis in tricuspid: thrombus, gradient. My guess is that Tricuspid TEER will dominate the market, when used w 3D IntraCardiac Echo. Also a safer procedure.

@KarolinskaUnsju @GilbertTangMD @RodrigoBagur @J_Sathananthan

@DFCapodanno The study result was almost entirely driven by TAVR within 6 mo in the conservative arm, which was included as unplanned hospitalization (!). That's why the curves look so strange with the inflection point at 6 mo. Not sure this is enough to tilt the guidelines.

@finnakerstrom @TAVRBot Not visible on fluoro… Large atria so might be hard to achieve sinus rythm?

@colum_owens @KarolinskaUnsju @BSCCardiology @TAVRBot Start with marker, then check upper crown vs leaflets after step 1A. Implant depth usually 4-5 mms in these. Check PCR London Valves for bicuspid study

@kspargias @TAVRBot Full points!

Reference: @GilbertTangMD @GreggWStone @TAVRBot @NatalieGlaser10 @MSettergren @MichaelDismorr

Would you do PCI for this TAVI patient (2)? 75 yr old, 90% LAD stenosis, sometimes chest pain, normal LVEF, high gradient AS Vmax 5 m/s @GilbertTangMD @MGtberg @phillipfreeman @NEJM

Acurate Prime #tavr CE marked. Great news. Soon to be rolled out at Karolinska and other European Centers. Will be interesting to see improved results with the added radial strength, a large study is planned here. @BSCCardiology

Good mid-term durability of the Acurate Neo #TAVR. Low rate (1,1% at mean 39 months FUP) of severe Hemodynamic Valve Deterioration. 433 core-lab analysed echos from @KarolinskaUnsju. @BSCCardiology @EuroInterventio